AmplioSpeech (formerly NiNiSpeech) today announced that Frank Baitman, former CIO of the US Social Security Administration and US Department of Health and Human Services, and Entrepreneur-in-Residence at the FDA, joins AmplioSpeech as General Manager USA. In his role, Frank will oversee AmplioSpeech’s US operations in the healthcare and education markets.
AmplioSpeech delivers digital speech-language pathology services to children and adults, combining an award-winning AI platform with a network of selected speech-language pathologists.
“In my previous positions I led business transformations for Cabinet agencies, leading to successful launch of digital solutions for better quality service for citizens, while reducing government expenses,” says Frank Baitman. “It’s time for 40 million Americans, suffering from communication disorders, to benefit from new models and technologies offered by the digital health revolution, and AmplioSpeech is well-positioned to bring dramatic change to speech-language therapy.”
Frank joins Dr. Kathleen Whitmire, former Director of School Services at the American Speech-Language-Hearing Association (ASHA), who leads the company’s activities in the education arena.
“180,000 speech-language pathologists strive to assist children and adults to better communicate,” says Dr. Whitmire. “AmplioSpeech is transforming the profession for the benefits of professionals and the individuals they serve, using technologies that seemed science fiction until now.”
Dr. Yair Shapira, CEO of NiNiSpeech said: “We are delighted to have Frank and Kathleen lead our activities across the USA, extending our reach from Europe and Israel into North America. Communication disorders cost the American economy $150–180B annually. AmplioSpeech has the means to significantly reduce the cost of treatment, while accelerating clients outcomes.”
AmplioSpeech is the leading provider of digital speech-Language pathology services, combining an expert AI platform with a network of selected speech-language pathologists, addressing the 12% of the world’s population who are suffering from speech and language disorders.
AmplioSpeech changes the way services are provided, improves clinical outcomes at reduced cost, while continuously measuring objective results. AmplioSpeech won prestigious awards in 4 continents and is the grantee of the European Union Horizon2020 program.